Newsletter

Long-Acting Injectable Nanoparticle and Lipid (LNP) Drug Shows Promising Results for Addiction Treatment: Inventage Lab Announces Non-Clinical Findings

Long-Acting Addiction Treatment: Inventage Lab to Announce Promising Results Inventage Lab, a leading research and development company specializing in long-acting injectable nanoparticle and lipid (LNP) technology, is set to reveal groundbreaking findings that could revolutionize drug addiction treatment. With a focus on securing stable prescriptions for their long-acting medications, the CEO of Inventage Lab, Kim […]